Fate Therapeutics (FATE) Current Leases (2019 - 2025)
Historic Current Leases for Fate Therapeutics (FATE) over the last 7 years, with Q3 2025 value amounting to $4.8 million.
- Fate Therapeutics' Current Leases fell 3107.5% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 3107.5%. This contributed to the annual value of $7.4 million for FY2024, which is 2007.77% up from last year.
- Latest data reveals that Fate Therapeutics reported Current Leases of $4.8 million as of Q3 2025, which was down 3107.5% from $5.7 million recorded in Q2 2025.
- Fate Therapeutics' Current Leases' 5-year high stood at $7.4 million during Q4 2024, with a 5-year trough of $4.4 million in Q1 2021.
- For the 5-year period, Fate Therapeutics' Current Leases averaged around $5.8 million, with its median value being $5.7 million (2022).
- In the last 5 years, Fate Therapeutics' Current Leases soared by 13245.52% in 2021 and then plummeted by 3107.5% in 2025.
- Over the past 5 years, Fate Therapeutics' Current Leases (Quarter) stood at $5.6 million in 2021, then rose by 0.91% to $5.6 million in 2022, then increased by 9.74% to $6.2 million in 2023, then increased by 20.08% to $7.4 million in 2024, then tumbled by 35.94% to $4.8 million in 2025.
- Its Current Leases was $4.8 million in Q3 2025, compared to $5.7 million in Q2 2025 and $6.5 million in Q1 2025.